Discover how Bova collaborates with vets to refine formulations and advance veterinary compounding. Contact your Account Manager or email us to learn more.
Discover how Bova collaborates with vets to refine formulations and advance veterinary compounding. Contact your Account Manager or email us to learn more.
Meet Yuki Age: 6 months Breed: Oriental Short Hair Diagnosis: Non-effusive (dry) form I bought home my dream almost 6 month old kitten Yuki and was concerned that he was having a bit of sneezing, I woke up to find he suddenly was wobbly, lethargic, had sunken eyes and was not himself at all especially not wanting his food. My…
Discover new therapeutic approaches for Feline Chronic Gingivostomatitis, including EIDD-1931, doxycycline, and meloxicam. Join Dr Andrea Harvey.
Explore how relational prescribing can transform veterinary behaviour cases. Join Dr Findy Wills to integrate medication with relationship-centred care.
Meet Tink Age: 10 months Breed: Devon Rex Diagnosis: Effusive (wet) form Tink had historically been an active and snuggly kitten, but very suddenly became more snuggly than usual sleeping all the time and then progressed to not eating as much or as quickly as she had been. For a kitten that had been food obsessed this was a red…
Meet Pacho Age: 4 months Breed: Domestic short hair Diagnosis: Effusive (wet) form Today Panchito is 10 months old, and we can proudly say he is a FIP survivor. We adopted him when he was just two months old. After a few weeks of love and care, we noticed he wasn’t thriving as kittens usually do. Our first visit to…
Join Dr James Oliver, Veterinary Ophthalmologist, for an in-depth look at ocular diseases caused by Feline Herpesvirus-1 (FHV-1). Through detailed clinical images, James will explain how to recognise, diagnose, and manage conditions such as:
Corneal ulceration and conjunctivitis
Symblepharon and corneal sequestrum
Eosinophilic keratitis
What happens when first-line FIP treatment isn’t enough? Dr Sally Coggins shares 2025 insights on treating tough FIP cases—molnupiravir, paxlovid, rescue therapy, and shorter, safer treatment protocols.